Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intranasal insulin improves memory in humans.

Christian Benedict1, Manfred Hallschmid, Astrid Hatke

  • 1Department of Neuroendocrinology, University of Lübeck, Ratzeburger Allee 160, Haus 23a, 23538 Lübeck, Germany. benedict@kfg.uni-luebeck.de

Psychoneuroendocrinology
|August 4, 2004
PubMed
Summary

This study examined whether long-term nasal delivery of insulin could boost memory and mood in healthy adults. Researchers found that eight weeks of treatment significantly improved the ability to recall information later and helped participants feel more confident and less angry. These benefits occurred without changing blood sugar levels, suggesting a direct effect on the brain. This approach might offer a new way to support cognitive health in conditions like Alzheimer's disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in sleep architecture and nocturnal oxygenation across obstructive sleep apnea severity: an observational hospital-based study.

Biology of sex differences·2026
Same author

Associations between wearable-device-measured daytime and nighttime light exposures and dementia risk: A prospective cohort study.

General psychiatry·2026
Same author

Wearable-Derived Diurnal Alignment Between Physical Activity and Device Temperature Predicts Future Disease and Mortality Risk.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Swiss obesity clinical practice guidance.

Swiss medical weekly·2026
Same author

Body-weight-specific and shared metabolomic responses to acute sleep loss in young adults.

Journal of translational medicine·2026
Same author

Association of Prodromal Parkinson's Disease-Like Features in Long COVID With Dream-Enactment Behaviours.

Journal of sleep research·2026

Area of Science:

  • Neuroscience research within intranasal insulin cognitive enhancement
  • Clinical pharmacology and behavioral neurology

Background:

Prior research has shown that short-term insulin exposure might boost cognitive performance. That uncertainty drove the need to investigate if longer durations of brain-targeted insulin activity yield lasting benefits. It was already known that insulin receptors exist in high concentrations within the hippocampus and limbic system. Previous work demonstrated that systemic insulin delivery could influence memory, yet this approach often causes unwanted metabolic side effects. No prior work had resolved whether chronic intranasal delivery could safely target these brain regions. This gap motivated the current investigation into prolonged hormonal administration. Researchers aimed to determine if this delivery method avoids systemic glucose fluctuations while altering cognitive outcomes. The study builds upon existing evidence linking metabolic signaling to human memory processes.

Purpose Of The Study:

The aim of this study was to evaluate the effects of prolonged brain-targeted insulin on human memory. Researchers sought to determine if this specific delivery method could safely improve cognitive performance. The investigation addressed whether long-term hormonal exposure influences hippocampus-dependent declarative memory functions. A secondary goal involved assessing potential changes in mood states among healthy participants. The team hypothesized that direct access to the cerebrospinal fluid would yield cognitive benefits. They also aimed to confirm that this route avoids systemic metabolic side effects like glucose fluctuations. This study was motivated by the need to find non-invasive treatments for memory-related impairments. The researchers designed the experiment to provide clear evidence regarding the efficacy of this hormonal intervention.

Keywords:
cognitive enhancementhippocampal functionhormonal therapyneuropsychology

Frequently Asked Questions

The researchers propose that chronic nasal insulin administration enhances declarative memory by targeting hippocampal receptors. Participants showed a significant increase in delayed word recall, moving from 2.92 in the placebo group to 6.20 in the insulin-treated group, suggesting a direct cognitive benefit.

The study utilized human regular insulin at a dosage of 40 international units administered four times daily. This specific regimen was chosen to ensure consistent brain exposure while avoiding systemic metabolic side effects like hypoglycemia.

The intranasal route is necessary because it allows the substance to bypass the blood-brain barrier and reach the cerebrospinal fluid directly. This pathway ensures that the hormone acts on limbic and hippocampal structures without altering peripheral blood glucose levels.

Related Experiment Videos

Main Methods:

Review approach involved a double-blind, between-subject experimental design to evaluate hormonal impacts. Thirty-eight healthy volunteers participated in an eight-week intervention period. Investigators administered human regular insulin at a daily frequency of four doses. Each individual dose consisted of forty international units delivered through the nasal cavity. The team monitored blood glucose and plasma hormone levels to ensure systemic stability. Researchers assessed cognitive performance using standardized word list recall tasks for memory evaluation. They also utilized the Stroop test to measure changes in attention among the subjects. Statistical comparisons between the placebo and treatment groups determined the significance of all observed behavioral shifts.

Main Results:

Key findings from the literature indicate that delayed word recall improved significantly after eight weeks of treatment. Participants receiving the hormone recalled 6.20 words compared to 2.92 words in the placebo group. This performance difference reached statistical significance with a p-value below 0.05. Subjects reported reduced anger levels with a p-value of less than 0.02. Enhanced self-confidence was also documented with a p-value under 0.03. Blood glucose and plasma hormone concentrations remained stable across both experimental conditions. These results suggest that the intervention directly affects brain activity without causing systemic metabolic changes. The data support the hypothesis that prolonged administration safely improves specific cognitive and emotional domains.

Conclusions:

Synthesis and implications suggest that chronic nasal insulin delivery directly influences human brain function. The evidence indicates that this method enhances memory performance without triggering systemic metabolic disturbances. These findings imply that such hormonal interventions could support cognitive health in clinical populations. The authors propose that this strategy might be relevant for managing memory impairments seen in Alzheimer's disease. The results demonstrate that mood states like anger and self-confidence are also sensitive to this treatment. This work highlights the potential for non-invasive brain-targeted therapies. Future applications may focus on translating these benefits to patients with neurodegenerative conditions. The study confirms that long-term administration remains safe and effective for healthy individuals.

The researchers measured declarative memory using immediate and delayed word list recall tasks. These metrics were chosen to isolate hippocampus-dependent cognitive functions, which are known to be sensitive to insulin receptor signaling in the brain.

Participants reported reduced anger and enhanced self-confidence after the eight-week intervention. These mood improvements were statistically significant, with anger reduction at p < 0.02 and self-confidence enhancement at p < 0.03, indicating a positive psychological impact.

The authors propose that these findings are relevant for treating memory disorders like Alzheimer's disease. They suggest that the absence of systemic side effects makes this a promising candidate for future clinical applications in neurodegenerative populations.